Fig. 2From: Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapyTIME classification based on PD-L1 expression and infiltration of immune cells, mainly tumor-infiltrating lymphocytes (TIL), in the tumor microenvironment. TIME, tumor immunity in the microEnvironmentBack to article page